Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 7, 2025Minerva MedicaOpen Access

Therapeutic approaches in the management of chronic kidney disease: the past, the present, and the future

View Full Paper
Ask AI
Bookmark
Share

Authors

GDGeorgia DoumaniPTPanagiotis TheofilisAVAikaterini Vordoni

Discussion

Loading...

Member takes

Overview

This review highlights therapeutic approaches for chronic kidney disease, emphasizing advances in RAAS blockade and SGLT2 inhibitors.

Key Points

  • Significant advancements in chronic kidney disease treatment have improved patient outcomes and reduced progression.
  • Emerging therapeutic options, such as SGLT2 inhibitors and GLP-1 receptor agonists, offer novel cardiorenal protection.
  • Future strategies in chronic kidney disease management aim to restore renal function, addressing disease drivers.
  • Personalized interventions and early diagnosis are critical for optimizing treatment effectiveness in chronic kidney disease.

Cite This Study

Doumani et al. (2025) studied this question.

synapsesocial.com/papers/68e585d0b1e78cc4e5f466c1https://doi.org/10.23736/s0026-4806.25.09747-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial2013 · 589 citations
  2. 2Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes2001 · 6,046 citations
  3. 3Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes2024 · 148 citations
  4. 4The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study2005 · 522 citations
  5. 5Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes2021 · 1,739 citations